The purpose of the study is to determine the effect on mood and anxiety symptoms of adding CPAP to the psychiatric treatment of patients with TRD (treatment resistant depression) and associated OSA (obstructive sleep apnea).
Primary objective: What is the effect on mood and anxiety symptoms of adding CPAP to the psychiatric treatment of patients with TRD and associated OSA? Secondary objectives: 1. How common is co-morbid OSA in patients with treatment resistant unipolar depression referred to a tertiary Mood Disorders Clinic? 2. Is there a difference in daytime functioning (severity of depressive and anxiety symptoms, cognitive function, daytime sleepiness) and sleep quality between patients with TRD diagnosed with OSA compared with patients with TRD who have no OSA? 3. What is the association between sleep fragmentation and hypoxemia and the severity of depression in patients with TRD?
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
120
CPAP (Respironics: RemStar plus M-series) machines for treatment of obstructive sleep apnea training for participant required by registered sleep technologist
Providence Continuing Care Centre, Mental Health Services
Kingston, Ontario, Canada
RECRUITINGMontgomery Asberg Depression Rating Scale (MADRS)
Time frame: baseline and 6 weeks
Symbol digit modalities
Time frame: baseline and 6 weeks
Stroop Test
Time frame: baseline and 6 weeks
Trail-Making test
Time frame: baseline and 6 weeks
Pittsburgh Sleep Quality Index (PSQI)
Time frame: baseline and 6 weeks
Epworth Sleepiness Score (ESS)
Time frame: baseline and 6 weeks
Beck Anxiety Inventory (BAI)
Time frame: baseline and 6 weeks
SF-36 questionnaire
Time frame: baseline and 6 weeks
Profile of mood state (POMS)
Time frame: baseline and 6 weeks
HAM-D21
Hamilton depression inventory
Time frame: baseline and 6 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.